The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
The global Insulin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The major players in China Insulin market include Novo Nordisk, Eli Lilly, etc. The top 2 players occupy about 60% shares of the whole market. Tianjin and Jiangsu are main markets, they occupy about 60% of the whole market. Regular Human Insulin is the main type, with a share over 60%. Long Acting and Intermediate Acting are the main applications, which holds a share about 70%.
This report aims to provide a comprehensive presentation of the global market for Insulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin.
Report Scope
The Insulin market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Novo Nordisk
- Eli Lilly
- Sanofi-Aventis
- Tonghua Dongbao
- Ganlee
- United Laboratory
- Jiangsu Wanbang
Segment by Type
- Animal Insulin
- Regular Human Insulin
- Insulin Analogue
Segment by Application
- Short Acting
- Intermediate Acting
- Long Acting
- Pre-Mix Insulin
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Insulin Market Overview
1.1 Product Overview and Scope of Insulin
1.2 Insulin Segment by Type
1.2.1 Global Insulin Market Value Comparison by Type (2024-2030)
1.2.2 Animal Insulin
1.2.3 Regular Human Insulin
1.2.4 Insulin Analogue
1.3 Insulin Segment by Application
1.3.1 Global Insulin Market Value by Application: (2024-2030)
1.3.2 Short Acting
1.3.3 Intermediate Acting
1.3.4 Long Acting
1.3.5 Pre-Mix Insulin
1.4 Global Insulin Market Size Estimates and Forecasts
1.4.1 Global Insulin Revenue 2019-2030
1.4.2 Global Insulin Sales 2019-2030
1.4.3 Global Insulin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Insulin Market Competition by Manufacturers
2.1 Global Insulin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Insulin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Insulin Average Price by Manufacturers (2019-2024)
2.4 Global Insulin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin, Product Type & Application
2.7 Insulin Market Competitive Situation and Trends
2.7.1 Insulin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insulin Players Market Share by Revenue
2.7.3 Global Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Retrospective Market Scenario by Region
3.1 Global Insulin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Insulin Global Insulin Sales by Region: 2019-2030
3.2.1 Global Insulin Sales by Region: 2019-2024
3.2.2 Global Insulin Sales by Region: 2025-2030
3.3 Global Insulin Global Insulin Revenue by Region: 2019-2030
3.3.1 Global Insulin Revenue by Region: 2019-2024
3.3.2 Global Insulin Revenue by Region: 2025-2030
3.4 North America Insulin Market Facts & Figures by Country
3.4.1 North America Insulin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Insulin Sales by Country (2019-2030)
3.4.3 North America Insulin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insulin Market Facts & Figures by Country
3.5.1 Europe Insulin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Insulin Sales by Country (2019-2030)
3.5.3 Europe Insulin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Market Facts & Figures by Country
3.6.1 Asia Pacific Insulin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Insulin Sales by Country (2019-2030)
3.6.3 Asia Pacific Insulin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Insulin Market Facts & Figures by Country
3.7.1 Latin America Insulin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Insulin Sales by Country (2019-2030)
3.7.3 Latin America Insulin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Insulin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Insulin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insulin Sales by Type (2019-2030)
4.1.1 Global Insulin Sales by Type (2019-2024)
4.1.2 Global Insulin Sales by Type (2025-2030)
4.1.3 Global Insulin Sales Market Share by Type (2019-2030)
4.2 Global Insulin Revenue by Type (2019-2030)
4.2.1 Global Insulin Revenue by Type (2019-2024)
4.2.2 Global Insulin Revenue by Type (2025-2030)
4.2.3 Global Insulin Revenue Market Share by Type (2019-2030)
4.3 Global Insulin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Insulin Sales by Application (2019-2030)
5.1.1 Global Insulin Sales by Application (2019-2024)
5.1.2 Global Insulin Sales by Application (2025-2030)
5.1.3 Global Insulin Sales Market Share by Application (2019-2030)
5.2 Global Insulin Revenue by Application (2019-2030)
5.2.1 Global Insulin Revenue by Application (2019-2024)
5.2.2 Global Insulin Revenue by Application (2025-2030)
5.2.3 Global Insulin Revenue Market Share by Application (2019-2030)
5.3 Global Insulin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Insulin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk Insulin Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Insulin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly Insulin Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Sanofi-Aventis
6.3.1 Sanofi-Aventis Corporation Information
6.3.2 Sanofi-Aventis Description and Business Overview
6.3.3 Sanofi-Aventis Insulin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi-Aventis Insulin Product Portfolio
6.3.5 Sanofi-Aventis Recent Developments/Updates
6.4 Tonghua Dongbao
6.4.1 Tonghua Dongbao Corporation Information
6.4.2 Tonghua Dongbao Description and Business Overview
6.4.3 Tonghua Dongbao Insulin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tonghua Dongbao Insulin Product Portfolio
6.4.5 Tonghua Dongbao Recent Developments/Updates
6.5 Ganlee
6.5.1 Ganlee Corporation Information
6.5.2 Ganlee Description and Business Overview
6.5.3 Ganlee Insulin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ganlee Insulin Product Portfolio
6.5.5 Ganlee Recent Developments/Updates
6.6 United Laboratory
6.6.1 United Laboratory Corporation Information
6.6.2 United Laboratory Description and Business Overview
6.6.3 United Laboratory Insulin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 United Laboratory Insulin Product Portfolio
6.6.5 United Laboratory Recent Developments/Updates
6.7 Jiangsu Wanbang
6.6.1 Jiangsu Wanbang Corporation Information
6.6.2 Jiangsu Wanbang Description and Business Overview
6.6.3 Jiangsu Wanbang Insulin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jiangsu Wanbang Insulin Product Portfolio
6.7.5 Jiangsu Wanbang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Industry Chain Analysis
7.2 Insulin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Production Mode & Process
7.4 Insulin Sales and Marketing
7.4.1 Insulin Sales Channels
7.4.2 Insulin Distributors
7.5 Insulin Customers
8 Insulin Market Dynamics
8.1 Insulin Industry Trends
8.2 Insulin Market Drivers
8.3 Insulin Market Challenges
8.4 Insulin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
